Screener
Eikon Therapeutics, Inc. EIKN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $6,005 | $681 |
| Accrued expenses and other current liabilities | 29,319 | 44,298 |
| Operating lease liability, current | 9,740 | 10,028 |
| Total current liabilities | 45,064 | 55,007 |
| Operating lease liability, non-current | 245,091 | 247,291 |
| Other non-current liabilities | 10,000 | 10,000 |
| Total liabilities | 300,155 | 312,298 |
| Commitments and contingencies (see Note 7) |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s total current liabilities?
- Eikon Therapeutics, Inc. (EIKN) reported total current liabilities of $45.06M in Q1 2026.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Eikon Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude